Menu
US
bispecifics-in-oncology-1920x400.jpg
Literature - Publication Review

Research and characterization of bispecific antibodies for cancer immunotherapies

Literature review on BsAb therapeutic research and discovery

Bispecific antibodies (BsAbs) are a rapidly growing area of immunotherapy, garnering attention as a next-generation strategy for treating cancer. BsAb characterization is essential for design, development, efficacy, and safety assessment.

In this literature review, we describe several functional approaches to characterize novel BsAbs targeting immune checkpoints and the tumor necrosis factor (TNF) superfamily, with easy-to-use immunoassays.

For research use only. Not for use in diagnostic procedures.

To view the full content please answer a few questions

By submitting my personal data, I acknowledge that Revvity Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy available here.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Download Resource

Research and characterization of bispecific antibodies for cancer immunotherapies

Download Literature - Publication Review